These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 8408470)

  • 21. Fractures and vertebral bone mineral density in patients with renal osteodystrophy.
    Piraino B; Chen T; Cooperstein L; Segre G; Puschett J
    Clin Nephrol; 1988 Aug; 30(2):57-62. PubMed ID: 3180516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Renal osteodystrophy-II-Recent therapeutic acquisitions (author's transl)].
    Sebert JL; Fournier AE; Gueris J; Marie P; Coevoet B; de Fremont JF; Lambrey G; Kuntz D
    Nouv Presse Med; 1977 Nov; 6(38):3533-7. PubMed ID: 341079
    [No Abstract]   [Full Text] [Related]  

  • 23. Renal osteodystrophy in children treated with 1,25-dihydroxy-cholecalciferol [1,25-(OH)2D3]. Histologic bone studies.
    Robitaille P; Marie PJ; Delvin EE; Lortie L; Glorieux FH
    Acta Paediatr Scand; 1984 May; 73(3):315-24. PubMed ID: 6547559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histological, hormonal, biochemical and radiological evaluation of vit. D therapy in osteodystrophy patients on RDT.
    Brancaccio D; Graziani G; Faccini JM; Banfi G; Pedoja G; Watson L
    J Urol Nephrol (Paris); 1976; 82(4-5):359-62. PubMed ID: 940182
    [No Abstract]   [Full Text] [Related]  

  • 25. Osteocalcin, iPTH, alkaline phosphatase and hand X-ray scores as predictive indices of histomorphometric parameters in renal osteodystrophy.
    Mazzaferro S; Coen G; Ballanti P; Bondatti F; Bonucci E; Pasquali M; Sardella D; Tomei E; Taggi F
    Nephron; 1990; 56(3):261-6. PubMed ID: 2077408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Renal osteodystrophy (I)].
    Covic A; Florea L; Ungureanu C; Covic M
    Rev Med Chir Soc Med Nat Iasi; 2000; 104(3):31-5. PubMed ID: 12089922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of strontium on bone metabolism in hemodialysis patients].
    Gerstenfeld S; Hinojosa L; Serrano Arias M; Menéndez Rodríguez P; Fernández Martín JL; Marchante JM; García Alonso JI; Sanz-Medel A; Cannata Andía JB
    Nefrologia; 2003; 23 Suppl 2():52-6. PubMed ID: 12778855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short-term administration of the bisphosphonate ibandronate increases bone volume and prevents hyperparathyroid bone changes in mild experimental renal failure.
    Geng Z; Monier-Faugere MC; Bauss F; Malluche HH
    Clin Nephrol; 2000 Jul; 54(1):45-53. PubMed ID: 10939756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Changes of PTH, 1,25(OH)2D3 and biochemistry in renal osteodystrophy].
    Jia JK; Lou DX; Zhu P
    Zhonghua Nei Ke Za Zhi; 1994 Jan; 33(1):33-6. PubMed ID: 8045186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term therapy of uremic osteodystrophy in adults with calcitriol.
    Moorthy AV; Harrington AR; Mazess RB; Simpson DP
    Clin Nephrol; 1981 Aug; 16(2):93-100. PubMed ID: 6894893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subtotal parathyroidectomy for secondary hyperparathyroidism.
    Zdon MJ; Iliopoulos JI; Thomas JH; Pierce GE; Hermreck AS; Friesen SR
    Surgery; 1984 Dec; 96(6):1103-8. PubMed ID: 6505963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is renal osteodystrophy reversible?
    Madsen S; Thaysen JH; Olgaard K; Heerfordt J; Løkkegaard H
    Proc Eur Dial Transplant Assoc; 1977; 14():433-41. PubMed ID: 341142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Biochemical and histological spectrum of renal osteodystrophy in Argentina].
    Douthat WG; Garay G; de Arteaga J; Fernández Martín JL; Cannata Andía JB; Massari PU
    Nefrologia; 2003; 23 Suppl 2():47-51. PubMed ID: 12778854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the skeletal kinetics of fluorine-18-fluoride ion with PET.
    Hawkins RA; Choi Y; Huang SC; Hoh CK; Dahlbom M; Schiepers C; Satyamurthy N; Barrio JR; Phelps ME
    J Nucl Med; 1992 May; 33(5):633-42. PubMed ID: 1569473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An investigation of biochemical and radiographic signs of hyperparathyroidism in chronic renal disease.
    Nilsson P; Malmaeus J; Wide L; Danielson BG
    Scand J Urol Nephrol Suppl; 1984; 84():I1-25. PubMed ID: 6393321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 1,25(OH)2D3 and 25-OHD3 in the treatment of renal osteodystrophy: comparison of combined versus 1,25(OH)2D3 administration alone.
    Coen G; Taccone Gallucci M; Bonucci E; Ballanti P; Bianchi AR; Bianchini G; Matteucci MC; Mazzaferro S; Picca S; Taggi F; Cinotti GA; Casciani CU
    Miner Electrolyte Metab; 1983; 9(1):19-27. PubMed ID: 6687749
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of childhood renal osteodystrophy with calcitriol or ergocalciferol.
    Hodson EM; Evans RA; Dunstan CR; Hills E; Wong SY; Rosenberg AR; Roy LP
    Clin Nephrol; 1985 Oct; 24(4):192-200. PubMed ID: 3877585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bisphosphonate kinetics in patients undergoing continuous ambulatory peritoneal dialysis: relations to dynamic bone histomorphometry, osteocalcin and parathyroid hormone.
    Joffe P; Hyldstrup L; Heaf JG; Pødenphant J; Henriksen JH
    Am J Nephrol; 1992; 12(6):419-24. PubMed ID: 1292341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Rheumatologic and radiologic symptoms of secondary hyperparathyroidism: retrospective long-term study of 175 chronic hemodialysis patients].
    Mayet WJ; Hermann E; Wandel E; Elsen A; Schadmand S; Klose KJ; Poralla T; Meyer zum Büschenfelde KH; Köhler H
    Z Rheumatol; 1991; 50(5):313-9. PubMed ID: 1776368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Secondary hyperparathyroidism and tertiary hyperparathyroidism chronic renal failure, uremia].
    Morio K; Koide K
    Nihon Rinsho; 1995 Apr; 53(4):958-64. PubMed ID: 7752492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.